mipomersen [nnon, phsu]
Apolipoprotein B [aapp, bacs]
synthesis [biof]
Inhibitor [qlco]
Introduction [hlca]
mipomersen [nnon, phsu]
Second [qnco]
Generation [tmco]
antisense oligonucleotide [bacs, irda, nnon]
Targeted [ftcn]
Human [humn]
Large [qnco]
Protein [aapp, bacs]
Synthesized [acty]
Liver [bpoc]
Play [dora]
Role [socb]
Human [humn]
lipoprotein metabolism [moft]
mipomersen [nnon, phsu]
Distribute [ftcn]
Liver [bpoc]
Decrease [qlco]
production [ocac]
Primary [qlco]
Structural protein [aapp, bacs]
Atherogenesis [patf]
Lipoproteins [aapp, bacs]
Including [ftcn]
Low density lipoprotein [aapp, bacs, lipd]
Reducing [qlco]
Plasma [bdsu]
Low Density Lipoprotein Cholesterol [bacs, strd]
Concentrations [menp]
Covered [ftcn]
Mode [ftcn]
Action [ftcn]
Pre-clinical [qlco]
development [phsf]
Clinical Trials [resa]
mipomersen [nnon, phsu]
Apo-B [aapp, bacs]
synthesis [biof]
Inhibitor [qlco]
Paper [mnob]
Understanding [menp]
PHARMACOKINETIC [resa]
pharmacodynamic [biof]
Characteristics [qlco]
mipomersen [nnon, phsu]
Insight [menp]
Clinical [qlco]
Efficacy [qlco]
Safety [hcpp]
Clinical Trials [resa]
mipomersen [nnon, phsu]
Dose-dependent [qnco]
Prolonged [tmco]
reductions [npop]
Low Density Lipoprotein Cholesterol [bacs, strd]
Apo-B [aapp, bacs]
Containing [ftcn]
Lipoproteins [aapp, bacs]
Including [ftcn]
Lipoprotein (a) [aapp, bacs]
Lp(a) [aapp, bacs]
Healthy Volunteers [popg]
Patients [podg]
Mild to moderate [qlco]
Hypercholesterolaemia [dsyn]
mipomersen [nnon, phsu]
Show [inpr]
To [qlco]
Decrease [qlco]
Apo-B [aapp, bacs]
Low Density Lipoprotein Cholesterol [bacs, strd]
Lp(a) [aapp, bacs]
Patients [podg]
Heterozygous [orga]
Homozygous [orga]
Familial hypercholesterolaemia [dsyn]
Lipid-lowering therapy [topp]
Expert Opinion [cnce]
mipomersen [nnon, phsu]
Show [inpr]
promise [idcn]
Adjunctive [topp]
Agent [chvf]
Reducing [qlco]
Apo-B [aapp, bacs]
Containing [ftcn]
Lipoproteins [aapp, bacs]
Patients [podg]
High Risk [qlco]
Atherosclerotic Cardiovascular Disease [dsyn]
Not [ftcn]
Target [ftcn]
intolerant [ftcn]
Statins [orch, phsu]
Short-term [tmco]
Efficacy [qlco]
Safety [hcpp]
mipomersen [nnon, phsu]
Established [qlco]
Concern [idcn]
Exist [cnce]
Long-term [tmco]
Potential [qlco]
hepatic steatosis [dsyn]
antisense oligonucleotide [bacs, irda, nnon]
